What is Solasta Bio?
Solasta Bio operates at the intersection of biotechnology and sustainable agriculture, specializing in the discovery and development of selective, greener insect control agents. The company leverages advanced peptide technology to disrupt specific biological functions in pest species, effectively mitigating crop damage while preserving beneficial insects and maintaining ecological balance. By prioritizing low-residue, high-selectivity compounds, Solasta Bio addresses the urgent global demand for modern, environmentally responsible pest management approaches that move beyond traditional chemical pesticides.
How much funding has Solasta Bio raised?
Solasta Bio has raised a total of $19M across 2 funding rounds:
Other Financing Round
$5M
Series A
$14M
Other Financing Round (2023): $5M with participation from Rubio Impact Ventures, Scottish Enterprise, Cavallo Ventures, Yield Lab Europe, and SIS Ventures
Series A (2024): $14M led by Forbion
Key Investors in Solasta Bio
Forbion
A global life sciences venture capital firm that invests in innovative therapeutics and sustainable biotechnology solutions across food, agriculture, and environmental technologies.
Cavallo Ventures
The venture capital arm of Wilbur Ellis, focused on integrating innovative technologies into agricultural markets and providing deep industry expertise to early-stage founders.
Scottish Enterprise
A national economic development agency of the Scottish Government dedicated to fostering innovation and economic growth within the region.
What's next for Solasta Bio?
With the successful closure of its Series A round, Solasta Bio is poised to transition from a research-intensive entity to a commercial-stage innovator. The strategic deployment of this capital will likely focus on expanding clinical-grade development pipelines, scaling manufacturing capabilities, and strengthening its intellectual property portfolio. As the agricultural sector faces increasing regulatory pressure to reduce chemical footprints, Solasta Bio's focus on sustainable, peptide-based alternatives positions it as a critical player in the future of global food security and environmental stewardship.
See full Solasta Bio company page
